New perspectives for targeting therapy in ALK-positive human cancers. Zhao S, Li J, Xia Q, Liu K, et al. Oncogene 2023;42:1959-1969.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao S, Li J, Xia Q, Liu K, et al. New perspectives for targeting therapy in ALK-positive human cancers. Oncogene 2023;42:1959-1969.
PMID: 37149665